These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 14530399)

  • 1. Dopamine-dependent neurodegeneration in rats induced by viral vector-mediated overexpression of the parkin target protein, CDCrel-1.
    Dong Z; Ferger B; Paterna JC; Vogel D; Furler S; Osinde M; Feldon J; Büeler H
    Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12438-43. PubMed ID: 14530399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkin is protective for substantia nigra dopamine neurons in a tau gene transfer neurodegeneration model.
    Klein RL; Dayton RD; Henderson KM; Petrucelli L
    Neurosci Lett; 2006 Jun; 401(1-2):130-5. PubMed ID: 16554120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Septin 4, the Drosophila homologue of human CDCrel-1, is toxic for dopaminergic neurons.
    Muñoz-Soriano V; Paricio N
    Eur J Neurosci; 2007 Dec; 26(11):3150-8. PubMed ID: 18028112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted overexpression of the parkin substrate Pael-R in the nigrostriatal system of adult rats to model Parkinson's disease.
    Dusonchet J; Bensadoun JC; Schneider BL; Aebischer P
    Neurobiol Dis; 2009 Jul; 35(1):32-41. PubMed ID: 19348945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of parkin in the rat nigrostriatal dopamine system protects against methamphetamine neurotoxicity.
    Liu B; Traini R; Killinger B; Schneider B; Moszczynska A
    Exp Neurol; 2013 Sep; 247():359-72. PubMed ID: 23313192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein.
    Lu XH; Fleming SM; Meurers B; Ackerson LC; Mortazavi F; Lo V; Hernandez D; Sulzer D; Jackson GR; Maidment NT; Chesselet MF; Yang XW
    J Neurosci; 2009 Feb; 29(7):1962-76. PubMed ID: 19228951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pael-R transgenic mice crossed with parkin deficient mice displayed progressive and selective catecholaminergic neuronal loss.
    Wang HQ; Imai Y; Inoue H; Kataoka A; Iita S; Nukina N; Takahashi R
    J Neurochem; 2008 Oct; 107(1):171-85. PubMed ID: 18691389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and chronic haloperidol treatments increase parkin mRNA levels in the rat brain.
    Nakahara T; Gotoh L; Motomura K; Kawanami N; Ohta E; Hirano M; Uchimura H
    Neurosci Lett; 2001 Jun; 306(1-2):93-6. PubMed ID: 11403966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Septin 4, the drosophila ortholog of human CDCrel-1, accumulates in parkin mutant brains and is functionally related to the Nedd4 E3 ubiquitin ligase.
    Muñoz-Soriano V; Nieto-Arellano R; Paricio N
    J Mol Neurosci; 2012 Sep; 48(1):136-43. PubMed ID: 22562816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nigral overexpression of alpha-synuclein in the absence of parkin enhances alpha-synuclein phosphorylation but does not modulate dopaminergic neurodegeneration.
    Van Rompuy AS; Oliveras-Salvá M; Van der Perren A; Corti O; Van den Haute C; Baekelandt V
    Mol Neurodegener; 2015 Jun; 10():23. PubMed ID: 26099628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1.
    Zhang Y; Gao J; Chung KK; Huang H; Dawson VL; Dawson TM
    Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13354-9. PubMed ID: 11078524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic overload of SEPT4, a parkin substrate that aggregates in Parkinson's disease, causes behavioral alterations but not neurodegeneration in mice.
    Ageta-Ishihara N; Yamakado H; Morita T; Hattori S; Takao K; Miyakawa T; Takahashi R; Kinoshita M
    Mol Brain; 2013 Aug; 6():35. PubMed ID: 23938054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
    Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
    Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DJ-1 and Parkin modulate dopamine-dependent behavior and inhibit MPTP-induced nigral dopamine neuron loss in mice.
    Paterna JC; Leng A; Weber E; Feldon J; Büeler H
    Mol Ther; 2007 Apr; 15(4):698-704. PubMed ID: 17299411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autosomal recessive juvenile parkinsonism: a key to understanding nigral degeneration in sporadic Parkinson's disease.
    Hattori N; Shimura H; Kubo S; Kitada T; Wang M; Asakawa S; Minashima S; Shimizu N; Suzuki T; Tanaka K; Mizuno Y
    Neuropathology; 2000 Sep; 20 Suppl():S85-90. PubMed ID: 11037196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer.
    Georgievska B; Kirik D; Björklund A
    Exp Neurol; 2002 Oct; 177(2):461-74. PubMed ID: 12429192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of overexpression of wild-type or mutant parkin on the cellular response induced by toxic insults.
    Hyun DH; Lee M; Halliwell B; Jenner P
    J Neurosci Res; 2005 Oct; 82(2):232-44. PubMed ID: 16130151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system.
    Kirik D; Rosenblad C; Burger C; Lundberg C; Johansen TE; Muzyczka N; Mandel RJ; Björklund A
    J Neurosci; 2002 Apr; 22(7):2780-91. PubMed ID: 11923443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. rAAV-mediated nigral human parkin over-expression partially ameliorates motor deficits via enhanced dopamine neurotransmission in a rat model of Parkinson's disease.
    Manfredsson FP; Burger C; Sullivan LF; Muzyczka N; Lewin AS; Mandel RJ
    Exp Neurol; 2007 Oct; 207(2):289-301. PubMed ID: 17678648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term overexpression of human wild-type and T240R mutant Parkin in rat substantia nigra induces progressive dopaminergic neurodegeneration.
    Van Rompuy AS; Lobbestael E; Van der Perren A; Van den Haute C; Baekelandt V
    J Neuropathol Exp Neurol; 2014 Feb; 73(2):159-74. PubMed ID: 24423640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.